Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 16,571 | 2,835 | N/A |
| Receivables | 1,422 | 1,024 | N/A |
| Inventories | 424 | 450 | N/A |
| TOTAL | $18,695 | $4,567 | $N/A |
| Non-Current Assets | |||
| PPE Net | 728 | 941 | N/A |
| Investments And Advances | 500 | 1,432 | 0 |
| Other Non-Current Assets | 4,966 | 2,602 | 0 |
| TOTAL | $6,194 | $4,975 | $N/A |
| Total Assets | $24,889 | $9,542 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 3,253 | 2,710 | 0 |
| Other current liabilities | 1,580 | 1,192 | N/A |
| TOTAL | $11,269 | $9,544 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 8,869 | 9,924 | N/A |
| Deferred Revenues | 830 | 1,074 | N/A |
| Other Non-Current Liabilities | 3,000 | 3,000 | 0 |
| TOTAL | $15,505 | $17,295 | $N/A |
| Total Liabilities | $26,774 | $26,839 | $N/A |
| Shareholders' Equity | |||
| Retained earnings | -113,970 | -95,631 | N/A |
| Other shareholders' equity | 82,881 | 0 | 0 |
| TOTAL | $-1,885 | $-17,297 | $N/A |
| Total Liabilities And Equity | $24,889 | $9,542 | $0 |